We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients (MEL58)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01585350
First Posted: April 25, 2012
Last Update Posted: August 12, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Virginia
National Cancer Institute (NCI)
Oncovir, Inc.
Information provided by (Responsible Party):
Craig L Slingluff, Jr, University of Virginia
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)